Chemfab Alkalis Q4 FY26: A Better Quarter, but FY27 hinges on execution

Chemfab Alkalis Limited closed Q4 FY26 with a sequential improvement in operating performance, even as the year reflected pressure from volatile chlor-alkali pricing and a sharp slowdown in OPVC demand tied to government funding. For Q4 FY26, the company reported revenue from operations of INR 68.74 crore, up 10.57% quarter-on-quarter, while operational EBITDA rose to INR 8.36 crore from INR 5.17 crore in Q3 FY26. Operational EBITDA margin improved to 12.16% from 8.32%.

Profitability still remained modest at the consolidated segment level, with profit before tax at INR 2.30 crore in Q4 FY26 versus a loss of INR 1.38 crore in Q3 FY26. Management attributed the sequential improvement largely to better ECU realisations in chlor-alkali, supported by a brief spike in global caustic prices in March 2026.

The bigger story is the setup for FY27. Management believes caustic prices have largely bottomed out, the technology modernisation programme is already commissioned, and the captive hybrid power plant is expected to begin supplying power from the last week of May 2026. In OPVC, the company is waiting for meaningful fund disbursements to resume under Jal Jeevan Mission 2.0, which management expects from Q2 FY27.

Q4 FY26 performance: Chlor-alkali stabilises, OPVC remains soft

Chemfab operates two distinct business segments: a chlor-alkali division with 65,700 TPA caustic soda capacity and an OPVC pipes division with 20,000 TPA capacity.

In chlor-alkali, Q4 FY26 revenue from operations rose to INR 55.63 crore from INR 47.52 crore in Q3 FY26. EBITDA increased sharply to INR 5.27 crore versus INR 1.77 crore, and margins expanded to 9.47% from 3.72%. ECU realisations improved sequentially to INR 39,100 per MT from INR 38,500 per MT.

Management noted that global caustic prices improved meaningfully during March 2026 but retraced by end-April to pre-war levels, underscoring continued volatility. Even so, management stated they believe global caustic prices have now largely bottomed out.

OPVC had a weaker quarter. Q4 FY26 revenue from operations declined to INR 13.11 crore from INR 14.65 crore in Q3 FY26 and was far below INR 31.53 crore in Q4 FY25. EBITDA was INR 3.09 crore, with margins broadly steady at 23.57%. The segment reported a PBT loss of INR 1.04 crore.

Management explicitly linked the demand impact to the absence of Jal Jeevan Mission fund flows. The presentation states there were no funds released under JJM from October 2024 to March 2026, with only a small quantum released in March 2026.

Q4 FY26 financial snapshot

FY26 segment mix and what it signals

For FY26, the company disclosed a clear revenue mix between its two segments. Chlor-alkali contributed 68% of FY26 revenue, while OPVC contributed 32%. In absolute terms, chlor-alkali segment revenue for FY26 was INR 195.69 crore, and OPVC revenue was INR 93.47 crore.

The segment economics diverged materially. The chlor-alkali segment delivered PBIT of negative INR 1.17 crore in FY26 and a negative ROCE of -0.37% on capital employed of INR 320.28 crore. OPVC reported PBIT of INR 19.43 crore and ROCE of 11% on capital employed of INR 181.76 crore.

This highlights two realities visible in the presentation. First, chlor-alkali profitability is highly sensitive to ECU and energy costs. Second, OPVC continues to be the more attractive return segment, but demand visibility can swing sharply with government funding flows.

FY26 segment performance snapshot

Strategy and execution: modernisation, power, and OPVC scale-up

Chemfab’s FY27 narrative is anchored around three execution levers that management repeatedly highlighted.

First is the technology modernisation programme in chlor-alkali. The company states it has been completed and the new plant was commissioned on 27 November 2025. In the strategic upgrades slide, the investment is indicated at about INR 56 crore, with the objective to replace 1994-based electrolyser technology. Management expects meaningful operational cost efficiencies and support for higher operating volumes.

Second is the power efficiency project. The captive hybrid power plant is stated to be ready and awaiting final transmission line charging clearances. Management indicated power supply is expected from the last week of May 2026. The presentation indicates an investment of about INR 15 crore via an SPV, intended to reduce power costs.

Third is OPVC capacity expansion and order book diversification. The company positions itself as one of the earliest OPVC pipe manufacturers in India and states it currently has the largest operational capacity in India with six operational lines and 20,000 TPA capacity, producing pipes from 110 mm up to 630 mm. It also highlighted product and quality differentiation, including BIS compliance and a BIS certificate of appreciation for zero failures.

While OPVC demand in Q4 was weak, management stated progress in diversifying the order book with inclusion in multiple state-level projects beyond Jal Jeevan Mission. It expects the benefit of this broader base to become visible from Q2 FY27.

What management is effectively betting on in FY27

The forward-looking message in the presentation is qualitative but consistent. Management expects FY27 to be materially stronger than FY26, supported by stabilising caustic realisations, cost efficiencies from the modernised plant, commencement of hybrid power supply, and revival in OPVC demand as government disbursements resume.

On the demand side, the presentation notes that the Union Cabinet approved the extension of Jal Jeevan Mission 2.0 with revised guidelines on 10 March 2026, and states meaningful disbursements are expected to commence from Q2 FY27. It also cites a higher budgetary allocation of INR 67,600 crore for JJM in 2026-27. Separately, AMRUT 2.0 is presented as another demand driver for urban water and sanitation infrastructure, with a stated FY27 budget allocation of INR 8,000 crore.

However, the FY26 financials also underline balance sheet pressure from capex and the transition year. Standalone finance cost rose to INR 7.54 crore in FY26, and borrowings increased, with long-term borrowings of INR 81.43 crore and short-term borrowings of INR 41.49 crore. Cash and bank balances were INR 0.02 crore at FY26 year-end.

Takeaways

Chemfab Alkalis ended Q4 FY26 with a sequential pickup in operating metrics, led by better chlor-alkali realisations and improved segment margins. FY26, however, remained pressured by a weak chlor-alkali return profile and an OPVC slowdown linked to stalled Jal Jeevan Mission fund releases.

FY27 is positioned by management as a year of operating leverage, with the modernisation project already commissioned and the hybrid power plant expected to begin supply in late May 2026. In OPVC, the demand recovery is expected to align with resumption of meaningful JJM disbursements from Q2 FY27 and expanding participation beyond JJM-linked projects.

Whether FY27 becomes materially stronger will depend on how quickly the power savings flow through, how stable ECU remains, and the pace at which government-led water infrastructure spending converts into executable orders.